Insider trade

Director sold ~$1.17M of IDXX shares in the open market

Traded Sep 4, 2026 · Filed Sep 9, 2026

Idexx LaboratoriesIDXX

~$1.17M
Reported value · 2,203 sh @ $532.0826: 9,568
Holds after · shares reported: -3.3%
stock since the trade · S&P 500 -0.8%, $535.38 → $517.75 on Oct 1

Why it stands out

A board member of Idexx Laboratories sold $1.17M of Idexx Laboratories shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 4, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 9, 2026

Director$1M+

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,172,178

Shares × reported transaction price

Timing vs results

31 days after results of Aug 4, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $535.38 on Sep 4, 2026, within 2% of its 52-week low, after a 2% drop over the previous 30 trading days

52-week range $526.44 (Jun 30, 2026) to $766.68 (Nov 25, 2025), 4% of the way up, from 252 adjusted closes. 30 trading days earlier: $544.32 on Jul 24, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-0.0%	+0.6%	-0.6%

Past results only. Not a forecast.

Source receipt

Record ID: 0000874716-26-000127
Filed / recorded: Sep 9, 2026, 9:00 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: IDEXX LABORATORIES INC /DE
Issuer CIK: 874716
Ticker: IDXX
Reporting person: Lawrence D Kingsley
Relationship: Director
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Sep 4, 2026
Transaction code: S
Shares / units: 2,203
Price per share: $532.0826
Acquired / disposed: Disposed (D)
Shares owned after: 9,568
Ownership form: Direct
Amendment: No

Footnotes from the filing

Represents the weighted average price of the shares sold ranging from a low of $531.88 to a high of $532.14 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Around the same time

4w ago

2,203Shares · @ $114.17

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

4w ago

2,203Derivative units

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Director plans to sell ~$1.17M of Idexx Laboratories

Planned, from pay4w ago